Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready
UNIVERSITAET ULM is currently navigating the patent prosecution process within the Biotechnology & Pharmaceuticals technology area. The portfolio includes 5 pending office actions, which indicates a steady level of activity in securing intellectual property for their research. This workload is distributed among 5 distinct examiners, suggesting that the university's innovations are being reviewed by several different technical specialists.
The data shows that the prosecution is also divided across 5 distinct art units. This high level of distribution for a portfolio of this size implies that the university's research spans a wide variety of technical niches within the biotechnology and pharmaceutical sectors. Practitioners must be prepared to handle the diverse requirements and examination styles of these different art units to achieve successful results.
WOODALL, NICHOLAS W is the busiest examiner for this portfolio, currently overseeing 1 pending office action. With the pending matters spread so thinly across different examiners and art units, the prosecution strategy must be highly adaptable. The outcome for each application will be heavily influenced by the specific practices of the individual examiner and the art unit to which it is assigned.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (40%) |
| §103 only | 2 (40%) |
| Multi-statute (no §101) | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WOODALL, NICHOLAS W | 1 | 82.1% | +13.3% |
| NICKOL, GARY B | 1 | 46.6% | +33.3% |
| CHANDRA, GYAN | 1 | 71.3% | +27.5% |
| BOESEN, CHRISTIAN C | 1 | 76.0% | +21.1% |
| RODRIGUEZ, RAYNA B | 1 | 33.6% | +19.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18689178 | RIGID, CURVED LARYNGOSCOPE | WOODALL, NICHOLAS W | 33d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18274624 | METHOD AND MEANS FOR MODULATING B-CELL MEDIATED IMMUNE RESPONSES | NICKOL, GARY B | — |
| 18274605 | METHOD AND MEANS FOR MODULATING B-CELL MEDIATED IMMUNE RESPONSES | CHANDRA, GYAN | — |
| 17996457 | METHOD FOR PROVIDING A MEDICAMENT COMBINATION AND DATA CARRIER WITH SOFTWARE | BOESEN, CHRISTIAN C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17255963 | NEW MOLECULAR TWEEZERS AGAINST NEUROLOGICAL DISORDERS AND VIRAL INFECTIONS | RODRIGUEZ, RAYNA B | 29d overdue |
| 18689178 | RIGID, CURVED LARYNGOSCOPE | WOODALL, NICHOLAS W | 33d |
| 18274624 | METHOD AND MEANS FOR MODULATING B-CELL MEDIATED IMMUNE RESPONSES | NICKOL, GARY B | — |
| 18274605 | METHOD AND MEANS FOR MODULATING B-CELL MEDIATED IMMUNE RESPONSES | CHANDRA, GYAN | — |
| 17996457 | METHOD FOR PROVIDING A MEDICAMENT COMBINATION AND DATA CARRIER WITH SOFTWARE | BOESEN, CHRISTIAN C | — |
| Art Unit | Apps |
|---|---|
| 3775 | 1 |
| 1643 | 1 |
| 1674 | 1 |
| 1623 | 1 |
| 1628 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18689178 | RIGID, CURVED LARYNGOSCOPE | WOODALL, NICHOLAS W | 3775 | §103 | Final Rejection | 33d | Pending | Mar 05, 2024 |
| 18274624 | METHOD AND MEANS FOR MODULATING B-CELL MEDIATED IMMUNE RESPONSES | NICKOL, GARY B | 1643 | §101§102§112DP | Non-Final OA | — | Pending | Jul 27, 2023 |
| 18274605 | METHOD AND MEANS FOR MODULATING B-CELL MEDIATED IMMUNE RESPONSES | CHANDRA, GYAN | 1674 | §102§103§112 | Non-Final OA | — | Pending | Jul 27, 2023 |
| 17996457 | METHOD FOR PROVIDING A MEDICAMENT COMBINATION AND DATA CARRIER WITH SOFTWARE | BOESEN, CHRISTIAN C | 1623 | §101§103§112 | Non-Final OA | — | Pending | Oct 18, 2022 |
| 17255963 | NEW MOLECULAR TWEEZERS AGAINST NEUROLOGICAL DISORDERS AND VIRAL INFECTIONS | RODRIGUEZ, RAYNA B | 1628 | §103 | Final Rejection | 29d overdue | Pending | Dec 23, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUNIVERSITAET ULM has 5 pending office actions as of October 2026, spread across 5 art units and 5 examiners.
Nicholas W Woodall has the most, with 1 of UNIVERSITAET ULM's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
